Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

NCT00723359

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Mount Sinai Medical Center New York, United States
View Trial Details
Completed

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

NCT00002543

Conditions
Brain and Central Nervous System Tumors, Burkitt Lymphoma, Central Nervous System Neoplasms, +33 more
Locations
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Boston Floating Hospital Infants and Children Boston, Massachusetts, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents

NCT00003635

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Scripps Clinic La Jolla, California, United States
View all 22 locations
View Trial Details
Completed

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

NCT00098436

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
Locations
  • American Health Network - North Illinois Street Indianapolis, Indiana, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View Trial Details

Related conditions